Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$21,524,027
-$2,265,681 QoQ
Shares Held
85,535
-21.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#585
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baker Avenue Asset Management, LP holds $87,152,887 across 10 Drug Manufacturers - General names. ABBV ranks #2 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,531 | $31,822,079 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
85,535 | $21,524,027 | |
| 3 | JNJ |
Johnson & Johnson
|
43,298 | $10,996,393 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
59,347 | $7,497,899 | |
| 5 | MRK |
Merck & Co., Inc.
|
51,784 | $6,654,244 | |
| 6 | AMGN |
Amgen Inc
|
15,621 | $5,656,676 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,475 | $1,006,909 | |
| 8 | PFE |
Pfizer Inc
|
40,733 | $980,850 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,524,027 | 85,535 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $23,789,708 | 109,383 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $24,987,437 | 109,359 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $25,396,927 | 109,687 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $19,561,006 | 105,382 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $22,171,825 | 105,822 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $18,764,942 | 105,599 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $21,755,186 | 110,164 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $17,372,574 | 101,286 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $16,619,356 | 91,265 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $13,950,089 | 90,018 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $12,361,098 | 82,927 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $10,820,301 | 80,311 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,326,266 | 71,069 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $18,535,374 | 114,692 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $16,071,781 | 119,751 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,966,145 | 110,774 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $34,267,784 | 211,386 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $34,537,019 | 255,074 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $25,021,633 | 231,961 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $25,207,705 | 223,790 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $22,803,793 | 210,717 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $22,088,543 | 206,146 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $15,598,640 | 178,087 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $16,580,442 | 168,878 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $5,710,592 | 74,952 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||